Title for MeetingAbstracts
Alphabetical listing of titles
AntiTachycardia pacing and cardiac events in the MADIT-II Trial.
Antitat gene is a candidate for both T-cell and stem-cell gene therapy.
Antitat is a candidate for both stem-cell and T-cell gene therapy.
Antitetanus immunity and HIV infection.
Antitoxoplasma IgG Detection by VIDAS-ELFA and ELISA and Use of Western Blot (WB) in Heart Transplant Recipients (HTX) and AIDS Patients.
Antituberculosis activity and side-effect profiles of 8 new quinolones optimized for antimycobacterial effects.
Antituberculosis drug regimen side effects in 152 HIV/AIDS patients.
Antituberculosis vaccines: recombinant M. smegmatis vs. BCG.
Antitubulin drugs inhibit HIV-1 replication by blocking tyrosine phosphorylases. American Pediatric Society 104th annual meeting and Society for Pediatric Research 63rd annual meeting; 1994 May 2-5; Seattle.
Antitumor activity of interleukin-4 toxin in nude mice implanted with AIDS-associated Kaposi's sarcoma tumor.
Antiviral action of polyadenylic-polyuridylic acid against HIV in cell cultures: synergistic effect with AZT.
Antiviral Activities of Lactoferrin.
Antiviral activity and acceptance of two different triple combinations: d4T + indinavir + 3TC vs d4T + indinavir + ddI.
Antiviral Activity and Incidence of Resistance after Treatment for Two Years with Emtricitabine in Patients with Chronic Hepatitis B.
Antiviral activity and mechanism of action of 1263W94, a benzimidazole riboside inhibitor of human cytomegalovirus.
Antiviral activity and mode of action of a PAF-receptor antagonist, PMS-601.
Antiviral activity and pharmacokinetics of amprenavir with or without zidovudine/3TC in the cerebral spinal fluid of HIV-infected adults.
Antiviral activity and pharmacokinetics of T-20, an amphipathic helical peptide derived from gp41.
Antiviral activity and resistance profile of AG1549, a novel HIV-1 nonnucleoside reverse transcriptase inhibitor.
Antiviral activity and resistance profile of AG1776, a novel inhibitor of HIV-1 protease.
Antiviral activity and resistance profile of an HIV-1 protease inhibitor BMS-232632.
Antiviral activity and resistance profile of phosphazid - a novel prodrug of AZT.
Antiviral activity and safety of twice daily zalcitabine in combination with zidovudine (ZDV) plus a protease inhibitor (PI) in patients with HIV-1 infection.
Antiviral Activity and Selectivity of BAY 38-4766-a Novel Nonnucleosidic Inhibitor of Human Cytomegalovirus Replication.
Antiviral activity in murine AIDS models in relation to serum drug levels.
Antiviral activity of a new class of HIV protease inhibitor: distinct resistance and protein binding properties and bioavailability. Eleventh International Conference on Antiviral Research.
Antiviral activity of a new class of HIV-protease inhibitor with distinct resistance and protein binding properties.
Antiviral activity of Abacavir in combination with Tenofovir as backbone of HAART in heavily pretreated patients.
Antiviral activity of acriflavine and other acridine analogues as measured in vivo in friend leukemia virus carrying mice and in vitro on HIV-1 infected cells.
Antiviral Activity of Adefovir Dipivoxil (ADV) in HBeAg+ Chronic Hepatitis B infection.